Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a clinical-stage biopharmaceutical company advancing nature-derived psilocybin...
-
TORONTO, Ontario and HAIFA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a biopharmaceutical company...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Cleaning Validation - Best Practice in Pharmaceuticals (June 23rd - June 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Global cGMP Audit Readiness: FDA, EMA & PMDA Expectations (Mar 26, 2026)" training has been added to ResearchAndMarkets.com's offering.cGMP or...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Quality Control Laboratory Compliance Training: cGMP, GLP and FDA (Apr 22nd - Apr 23rd, 2026)" training has been added to ResearchAndMarkets.com's...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Quality Control Laboratory Compliance Training - cGMP, GLP and FDA Requirements (Apr 22nd - Apr 23rd, 2026)" training has been added to ...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Efficient Batch Record Design and Review Course (Apr 9th - Apr 10th, 2026)" training has been added to ResearchAndMarkets.com's offering.This online...
-
Spring 2026 RAM Release capabilities streamline review processes, improve data management, and empower technicians with enhanced mobile productivity.
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "APIs in Focus: Understanding ICH, GMP and Supply Chain Excellence (Apr 29th - Apr 30th, 2026)" training has been added to ResearchAndMarkets.com's...
-
Applied StemCell and Cellipont collaborate to enable seamless iPSC cell therapy development from early engineering to GMP production and scale-up.